FMP
AIM ImmunoTech Inc. Executes Reverse Stock Split
Jun 18, 2025 1:00 AM - Andrew Wynn
Image credit: Google Images
AIM ImmunoTech Inc. (AMEX:AIM) is a biotechnology company focused on developing immune-based therapies for the treatment of various diseases. The company is known for its work in immunotherapy, which involves using the body's immune system to fight diseases. AIM competes with other biotech firms in the immunotherapy space, striving to bring innovative treatments to market.
On June 17, 2025, AIM executed a reverse stock split at a ratio of 100 for 1. This strategic move is designed to increase the per-share market price of AIM's common stock. As highlighted by GlobeNewswire, the reverse stock split took effect on June 12, 2025, and temporarily changed the company's ticker symbol on the OTC Pink to AIMID for 20 trading days.
The primary goal of this reverse stock split is to help AIM regain compliance with the NYSE American's Listing Qualifications. This decision was approved by the company's stockholders during a Special Meeting on April 30, 2025. They agreed to amend the Certificate of Incorporation to allow for a reverse stock split at a ratio of up to 1-for-100, as determined by the Board of Directors.
Following the reverse stock split, AIM's stock price experienced a significant increase. The stock, trading on the AMEX exchange, is currently priced at $10.15. The stock reached a low of $8.50 and a high of $10.15 today, marking its highest price for the year.
AIM's market capitalization stands at approximately $7.76 million. This financial metric represents the total market value of the company's outstanding shares. The reverse stock split and subsequent price increase aim to enhance AIM's market position and attract more investors.
Other Blogs
Nov 22, 2024 5:08 AM - Parth Sanghvi
Fundamental Analysis: Principles, Types, and How to Use It
Fundamental analysis is one of the most essential tools for investors and analysts alike, helping them assess the intrinsic value of a stock, company, or even an entire market. It focuses on the financial health and economic position of a company, often using key data such as earnings, expenses, ass...
Dec 17, 2024 8:58 AM - Sanzhi Kobzhan
Examining Tesla’s Financial Health Using FinancialModelingPrep’s Ratios API
Tesla, one of the world’s most talked-about electric vehicle manufacturers, attracts a lot of attention from investors and market watchers. By examining a snapshot of Tesla’s financial ratios—such as those provided by FinancialModelingPrep’s Ratios API—we can get a clearer picture of the company’s f...
Dec 22, 2024 7:59 AM - Sanzhi Kobzhan
Two great Software Platform Stocks Similar to Palantir (PLTR)
When it comes to cutting-edge software and data analytics, Palantir Technologies (NYSE: PLTR) is often front and center. But for many investors, it’s important to consider alternative or complementary stocks in the same sector that may offer robust growth potential. As PLTR looks expensive (overvalu...
